Medical Device News Magazine

Summus Raises $19.5 Million

To expand solutions solving the access problem in specialty care

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Summus, the leading virtual health company focused in specialty care, announced today that it raised $19.5 million to support the company’s continued growth and work to solve the access problem to high quality physicians. Following a previous investment round in 2022, Summus has now raised $70 million to expand its innovative approach to care.

The company’s proprietary marketplace model empowers patients, families, caregivers and physicians to share and access high quality specialty expertise — across all health questions, at any point in the journey. By accelerating access to high quality physicians, Summus delivers best-in-class clinical guidance, advocacy and navigation. Summus works with leading employers, health plans, physician groups and leading medical institutions to provide a broad portfolio of solutions that improves access to quality care and improves outcomes.

“Durable, category defining companies naturally evolve and expand their aperture to serve more people over time. We are investing to meet the explosive demand for Summus solutions across the healthcare ecosystem,” said Mitchell Rales, Co-founder and Executive Chairman, Danaher Corporation.

In supporting more than 2 million lives, 98% of Summus members report that they better understand what to do in the next stage of their healthcare journey. Since 2020, consistent feedback from Summus members and physicians reflect universal recognition of the access and insights through Summus that would not otherwise have been available.

“The value of accessing high quality physicians in an expedient manner is vital — for peace of mind, optimizing treatment paths, and driving better outcomes. We continue our commitment to put high quality physicians, the most trusted party in healthcare, at the center of decisions big and small,” said Julian Flannery, Summus CEO and Co-founder.

The investment will focus on further scaling growth for the organization, including meeting demand for Summus’ innovative solution to support primary care physicians in a peer-to-peer environment, and enhancing condition-specific, personalized journeys for patients to access the best care with the most trusted physicians.

“We remain inspired by the Summus team and the value proposition they bring to the healthcare ecosystem. In providing access to thousands of the world’s most talented physicians to patients, families and physicians who need their expertise, we see Summus changing lives on a daily basis. We’re grateful to have the opportunity to continue to support Summus as they expand their capabilities to solve the critical issues of access to quality healthcare today,” said Rick Buhrman, Co-Founder and Co-CEO, Sator Grove Holdings. “I am impressed by the continued innovation, commitment and expertise of the Summus team, and am thrilled to see their growth and recognition in the market for bringing new solutions to physicians and patients around the world.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”